As we take stock of 2025…
Below is a reminder of how the year went at Neurochecklists.
22 NEW CHECKLISTS
Acute haemorrhagic leukoencephalitis (AHLE)
Arterial tortuosity syndrome (ATS)
Benign paroxysmal torticollis (BPT)
Cervical artery dissection (CAD): recurrence
Creutzfeldt Jakob disease (CJD) treatment
***
Developmental coordination disorder (DCD)
Immune checkpoint inhibitor (ICI) paraneoplastic syndrome
Ischaemic stroke hand knob syndrome
KLHL11 paraneoplastic encephalitis
Senile dementia of the neurofibrillary tangle type (SDNFT)
280 UPDATED CHECKLISTS
Aadrenoleukodystrophy (ALD): management
Agyrophilic brain disease clinical features
Alzheimer’s disease (AD) drug treatments
Alzheimer’s disease (AD) risk factors
Alzheimer’s disease (AD): emerging investigations
Alzheimer’s disease (AD): protective factors
Alzheimer’s disease (AD): emerging investigations
Alzheimer’s disease (AD): investigational treatments
***
Anti GFAP cytopathy: management
Anti glycine receptor syndrome: clinical features
Anti Ma2 encephalitis syndrome: clinical features
Anti-MAG neuropathy: clinical features
Anti-seizure medications: teratogenicity risk
Antiphospholipid syndrome (APS) investigations
Arachnoid cysts: clinical features
Arterial dolichoectasia: clinical features
***
Autoimmune encephalitis: clinical features
Autonomic dysfunction: investigations
Behavioural variant FTD: clinical features
***
Biotidinase deficiency: clinical features
Brachial neuritis: investigations
CAA-related inflammation (CAAri)
CASPR2 autoimmune encephalitis: management
Cerebral amyloid angiopathy (CAA) investigations
Cerebral amyloid angiopathy (CAA) radiological features
***
Cerebral amyloid angiopathy (CAA) treatment
Cerebral amyloid angiopathy (CAA): clinical features
Cerebral amyloid angiopathy (CAA): haemorrhage types
Cerebral aneurysms: clinical features
Cerebral aneurysms: risk factors
Cerebral vein thrombosis (CVT): clinical features
Cerebral vein thrombosis (CVT): risk factors
Cerebrotendinous xanthomatosis (CTX): management
Cervical artery dissection (CAD): risk factors
***
CIDP: immunosuppressant treatment
Clinically isolated syndrome (CIS): MS risk
Cluster headache (CH): clinical features
Cluster headache (CH): co-morbid disorders
***
Corticobasal syndrome (CBS): clinical features
Covid 19 vaccine complications
Cryopyrin associated periodic fever syndrome
Dengue infection: neurological features
***
Distal hereditary motor neuropathy (dHMN): genetics
Down’s syndrome: neurological features
Drug-induced parkinsonism: risk factors
Duchenne muscular dystrophy (DMD): treatment
***
Embolic stroke of undetermined source (ESUS): management
Epilepsy and autoimmune disorders
Epilepsy with eyelid myoclonia
Epilepsy: psychiatric manifestations
Epileptic encephalopathy: classification
***
Episodic ataxia: summary checklist
Erdheim Chester disease: clinical features
Familial amyloid neuropathy (FAP): treatment
Familial partial epilepsy with variable foci
Fragile x tremor ataxia syndrome (FXTAS): clinical features
Frontotemporal brain sagging syndrome (FBSS)
Frontotemporal dementia (FTD): clinical features
Frontotemporal dementia (FTD): differential diagnosis
***
Frontotemporal dementia (FTD): management
Functional seizures: risk factors
Functional seizures: complications
Gene-specific epileptic encephalopathy: classification
GFAP encephalitis: clinical features
***
Giant cell arteritis (GCA): treatment
Giant tumefactive perivascular spaces
Guillain barre syndrome (GBS): prognosis
Hepatitis B virus (HBV) neurology
Huntington’s disease (HD): clinical features
Huntington’s disease (HD): treatment
Hypertrophic pachymeningitis: causes
***
Hypothalamic hamartoma: management
Idiopathic hypersomnia management
Idiopathic intracranial hypertension (IIH) clinical features
Idiopathic intracranial hypertension (IIH): dural venous sinus stenting
IgLON5 antibody disease: clinical features
IgLON5 antibody disease: management
Immune checkpoint inhibitor (ICI) myopathy
Immune mediated necrotizing myopathy (IMNM): causes
Inclusion body myositis (IBM): clinical features
Intra-arterial dolichoectasia features
***
Intracerebral haemorrhage (ICH): risk factors
Intracerebral haemorrhage (ICH): causes
Intracranial dural AV fistula (AVF)
Limbic predominant age-related tdp43 encephalopathy (LATE)
Lumbar puncture (LP): complications
Lumbosacral plexopathy: causes
Lyme neuroborreliosis: clinical features
***
Malformations of cortical development (MCD): other genes
Metachromatic leukodystrophy (MLD)
Migraine: evidenced preventative options
Mitochondrial POLG disorders: management
MOG antibody disease (MOGAD: outcome
MOG antibody disease (MOGAD): MRI features
Molybdenum cofactor deficiency: management
Motor neurone disease (MND): prognosis
***
Motor neurone disease (MND): protective factors
Motor neurone disease (MND): clinical features
Motor neurone disease (MND): differential diagnosis
Motor neurone disease (MND): investigational drug treatments
Motor neurone disease (MND): minor genetic risk factors
Motor neurone disease (MND): non-genetic risk factors
Motor neurone disease (MND): non-invasive ventilation
Motor neurone disease (MND): other genetic risk factors
Moyamoya disease: clinical features
***
Multifocal motor neuropathy (MMN): clinical features
Multiple sclerosis (MS) and seizures
Multiple sclerosis (MS): breastfeeding
Multiple sclerosis (MS): clinical features
Multiple sclerosis (MS): CSF analysis
Multiple sclerosis (MS): investigational treatments
Multiple sclerosis (MS): modifiable risk factors
Multiple sclerosis (MS): MRI features
Multiple sclerosis (MS): neurological features
Multiple sclerosis (MS): poor prognostic factors
***
Multiple sclerosis (MS): protective factors
Multiple system atrophy (MSA) clinical features
Multiple system atrophy (MSA) investigations
Multisystem proteinopathy: investigations
Musk myastheni gravis (MG): management
Musk myasthenia gravis (MG): management
Myasthenia gravis (MG): AChR antibody
Myasthenia gravis (MG): clinical features
Myasthenia gravis (MG): investigational treatments
Myasthenia gravis (MG): non-immunosuppression agents
***
Myasthenia gravis (MG): immunosuppression treatment
Myasthenia gravis (MG): triggers
Myasthenic crisis: risk factors
Myotonic dystrophy type 1: neurological features
Myotonic dystrophy: clinical features
***
Neoplastic meningitis: investigations
Neuroangiostrongyliasis: management
Neurological guidelines directory
Neuromyelitis optica (NMO): clinical differentials
Neuromyelitis optica (NMO): CSF analysis
Neuromyelitis optica (NMO): MRI features
Neuromyelitis optica (NMO): treatment
Neurosarcoidosis: CSF analysis
***
Neurosarcoidosis: investigations
Neurosarcoidosis: cranial features
Niemann-Pick C disease: treatment
NMDAR encephalitis: atypical features
NMDAR encephalitis: investigations
NMDAR encephalitis: clinical features
Nodding syndrome: clinical features
***
Non-convulsive status epilepticus (NCSE): clinical features
Normal pressure hydrocephalus (NPH): clinical features
Parkinsn’s disease (PD): investigational treatments
Parkinsn’s disease (PD): premotor features
Parkinson’s disease (PD) investigations
Parkinson’s disease (PD) neurological risk factors
Parkinson’s disease (PD): differential diagnosis
***
Parkinson’s disease (PD): genetic classification
Parkinson’s disease (PD): protective factors
Parkinson’s disease (PD): systemic features
Parkinson’s disease (PD): systemic risk factors
Paroxysmal kinesigenic dyskinesia (PKD) clinical features
Primary angiitis of the cns (PACNS) investigations
Primary lateral sclerosis (PLS) clinical features
Primary progressive aphasia non-fluent variant (NFVPPA)
***
Progressive multifocal leukoencephalopathy (PML): investigations
Progressive supranuclear palsy (PSP) clinical features
Progressive supranuclear palsy (PSP) differential diagnosis
Progressive supranuclear palsy (PSP): clinical features
Rasmussen’s encephalopathy (RE): management
Refractory epilepsy: drug treatments
Refractory epilepsy: interventional treatments
Refractory status epilepticus: treatment
***
Restless legs syndrome (RLS): clinical features
Rosai dorfman disease (RDD): differential diagnosis
Schistosomal meloradiculopathy
Seizures: neurological features
Sickle cell disease: neurological features
***
Sickle cell disease: treatments
Snake bite toxicity: clinical features
Spinocerebellar ataxia 27 (SCA 27)
Spinocerebellar ataxia 3 (SCA 3): clinical features
Spontaneous intracranial hypotension (SIH) clinical features
Spontaneous intracranial hypotension (SIH): treatment
***
Stiff person syndrome (SPS): investigational treatments
Stiff person syndrome (SPS): treatments
Subarachnoid haemorrhage (SAH): complications
Synaesthesia clinical features
***
Systemic seizures: manifestations
Traumatic brain injury (TBI): complications
Trigeminal neuralgia (TN): clinical features
TTR amyloidosis neuropathy: treatment
Tumefactive demyelination: causes
Tumefactive MS: differential diagnosis
***
Vein of Galen aneurysmal malformation (VGAM)
Viral encephalitis: management
West nile virus (WNV) infection: management
Wilson’s disease: MRI features
***
The Neurology Lounge 